Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Transitional Cell × durvalumab × Clear all

Phase

Status

Active not recruiting 4 Unknown 2 Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 30 Breast Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 15 Lung Neoplasms 15 Colorectal Neoplasms 14 Head and Neck Neoplasms 10 Ovarian Neoplasms 9 Neoplasms 9 Neoplasm Metastasis 8 Small Cell Lung Carcinoma 7 Recurrence 7 Urinary Bladder Neoplasms 6 Prostatic Neoplasms 6 Pancreatic Neoplasms 6 Melanoma 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Sarcoma 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Carcinoma, Renal Cell 5 Advanced Solid Tumors 5 Mesothelioma, Malignant 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Recurrent Squamous Cell Lung Carcinoma 3 Multiple Myeloma 3 Mesothelioma 3 Lymphoma, Large B-Cell, Diffuse 3 Kidney Neoplasms 3

Interventions

pembrolizumab 21 Gemcitabine 16 Cisplatin 14 Nivolumab 12 atezolizumab 11 Carboplatin 9 vinflunine 7 avelumab 6 Paclitaxel 6 Ipilimumab 5 enfortumab vedotin 4 Docetaxel 4 cabazitaxel 3 Taxes 3 Rogaratinib 3 Pemetrexed 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3 Injections 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 pemigatinib 2 lenvatinib 2 cabozantinib 2 Vitamin D 2 Ramucirumab 2 Everolimus 2 Biopsy 2 Bevacizumab 2 valrubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03871036 2025-03-06

ICRA

The Netherlands Cancer Institute

Phase 1/2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡